Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
The American Journal of Managed Care
|
February 19, 2019
Finding the right combination for neoadjuvant therapy in high-risk, stage III melanoma
Rodabe Amaria, Mary Caffrey
Immunotherapy
|
November 19, 2011
Novel therapies in melanoma
Benjamin Scheier, Rodabe Amaria, Karl Lewis, et al.
Advances in Experimental Medicine and Biology
|
December 30, 2004
Proprotein processing and pancreatic islet function
John Hutton, Christina Wasmeier, Rodabe Amaria, et al.
Journal for Immunotherapy of Cancer
|
February 29, 2024
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy
Allison Betof Warner, Omid Hamid, Krishna Komanduri, et al.
International Journal of Dermatology
|
November 21, 2017
Regressed melanocytic nevi secondary to pembrolizumab therapy: an emerging melanocytic dermatologic effect from immune checkpoint antibody blockade
Shakuntala H Mauzo, Michael T Tetzlaff, Kelly Nelson, et al.
Journal of Cutaneous Pathology
|
September 14, 2017
Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy-Report of 2 patients
Michael T Tetzlaff, Amir A Jazaeri, Carlos A Torres-Cabala, et al.
Journal for Immunotherapy of Cancer
|
February 3, 2024
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma
Rodabe Amaria, Anne Knisely, David Vining, et al.
Journal for Immunotherapy of Cancer
|
April 19, 2019
Correction to: Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis
Daniel H Johnson, Chrystia M Zobniw, Van A Trinh, et al.
Journal for Immunotherapy of Cancer
|
October 12, 2018
Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis
Daniel H Johnson, Chrystia M Zobniw, Van A Trinh, et al.
Journal of the National Cancer Institute
|
December 22, 2017
The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy
Jodi A McKenzie, Rina M Mbofung, Shruti Malu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
The American Journal of Managed Care
|
February 19, 2019
Finding the right combination for neoadjuvant therapy in high-risk, stage III melanoma
Rodabe Amaria, Mary Caffrey
Immunotherapy
|
November 19, 2011
Novel therapies in melanoma
Benjamin Scheier, Rodabe Amaria, Karl Lewis, et al.
Advances in Experimental Medicine and Biology
|
December 30, 2004
Proprotein processing and pancreatic islet function
John Hutton, Christina Wasmeier, Rodabe Amaria, et al.
Journal for Immunotherapy of Cancer
|
February 29, 2024
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy
Allison Betof Warner, Omid Hamid, Krishna Komanduri, et al.
International Journal of Dermatology
|
November 21, 2017
Regressed melanocytic nevi secondary to pembrolizumab therapy: an emerging melanocytic dermatologic effect from immune checkpoint antibody blockade
Shakuntala H Mauzo, Michael T Tetzlaff, Kelly Nelson, et al.
Journal of Cutaneous Pathology
|
September 14, 2017
Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy-Report of 2 patients
Michael T Tetzlaff, Amir A Jazaeri, Carlos A Torres-Cabala, et al.
Journal for Immunotherapy of Cancer
|
February 3, 2024
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma
Rodabe Amaria, Anne Knisely, David Vining, et al.
Journal for Immunotherapy of Cancer
|
April 19, 2019
Correction to: Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis
Daniel H Johnson, Chrystia M Zobniw, Van A Trinh, et al.
Journal for Immunotherapy of Cancer
|
October 12, 2018
Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis
Daniel H Johnson, Chrystia M Zobniw, Van A Trinh, et al.
Journal of the National Cancer Institute
|
December 22, 2017
The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy
Jodi A McKenzie, Rina M Mbofung, Shruti Malu, et al.
Page
of 2